dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Santoro, Armando |
dc.contributor.author | Su, Wu-Chou |
dc.contributor.author | Navarro Mendivil, Alejandro |
dc.contributor.author | Yang, James C. H. |
dc.contributor.author | Ardizzoni, Andrea |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Simonelli, Matteo |
dc.date.accessioned | 2022-08-10T06:25:28Z |
dc.date.available | 2022-08-10T06:25:28Z |
dc.date.issued | 2022-04 |
dc.identifier.citation | Santoro A, Su WC, Navarro A, Simonelli M, Yang JCH, Ardizzoni A, et al. Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer. Lung Cancer. 2022 Apr;166:170–7. |
dc.identifier.issn | 0169-5002 |
dc.identifier.uri | https://hdl.handle.net/11351/7972 |
dc.description | Inhibidores de ALK; Ceritinib; Ribociclib |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Lung Cancer;166 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Proteïnes quinases - Inhibidors |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Protein Kinase Inhibitors |
dc.subject.mesh | /adverse effects |
dc.title | Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.lungcan.2022.02.010 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inhibidores de proteínas cinasas |
dc.subject.decs | /efectos adversos |
dc.relation.publishversion | https://doi.org/10.1016/j.lungcan.2022.02.010 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Santoro A, Simonelli M] Department of Biomedical Sciences, Humanitas University, Milan, Italy. IRCCS Humanitas Research Hospital–Humanitas Cancer Center, Milan, Italy. [Su WC] Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan. [Navarro A, Felip E] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Yang JCH] National Taiwan University Cancer Center, Taipei, Taiwan. [Ardizzoni A] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy |
dc.identifier.pmid | 35298959 |
dc.identifier.wos | 000789861800003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |